Uncategorized

Palobiofarma Receives Venture Philanthropy Award from Foundation for Prader-Willi Research to Advance PBF-999 Development for Prader-Willi Syndrome Treatmenta

[Pamplona, Covina] – The Foundation for Prader Willi Research (FPWR) has provided a new venture philanthropy award, in the form of a convertible loan, to Palobiofarma S.L., a Spanish biopharmaceutical company focused on developing innovative treatments for serious diseases.

Palobiofarma Receives Venture Philanthropy Award from Foundation for Prader-Willi Research to Advance PBF-999 Development for Prader-Willi Syndrome Treatmenta Read More »

Anemia en lactantes

De acuerdo a las estadísticas médicas, los niños menores de 2 años y las mujeres embarazadas son los grupos más vulnerables en cuanto a la incidencia de la deficiencia de hierro y de la anemia por deficiencia de hierro.   La anemia por deficiencia de hierro, …

Anemia en lactantes Read More »

Scroll to Top